In breast cancer, LBH is considered an oncogene directly regulated by the Wnt/ β-catenin pathway, and LBH overexpression leads to a more aggressive basal differentiation of breast cancer (Lindley et al., 2015). Here, LBH is linked to breast carcinoma.